Claro Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,102
Closed -$201K 504
2025
Q1
$201K Buy
13,102
+680
+5% +$10.5K 0.03% 490
2024
Q4
$274K Sell
12,422
-154
-1% -$3.39K 0.04% 378
2024
Q3
$227K Buy
+12,576
New +$227K 0.03% 455
2019
Q1
Sell
-814
Closed -$18K 831
2018
Q4
$18K Buy
+814
New +$18K 0.01% 569